This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Steeper individual fines seen as China pushes for greater antitrust compliance

By MLex Staff ( June 11, 2025, 06:35 GMT | Comment) -- China’s antitrust authorities have steadily tightened individual accountability under the 2022 revised Antimonopoly Law, reinforcing the message that personal responsibility in antitrust violations carries significant financial and reputational risks. The trend first emerged in March with a landmark penalty against a business executive involved in a drug cartel case in Shanghai and has since extended to multiple other cases. Following a failed challenge to the Tianjin antitrust regulator’s pre-penalty decision, Lianhuan Pharmaceutical today announced receiving a collective fine of 61.03 million yuan ($8.5 million) for cartel agreements in the market for dexamethasone sodium phosphate, a key raw material for drug production....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections